Recently, in breast cancer cells, it has been shown that ERβ physically interacts with p53, reduces ERα-p53 binding, antagonizes ERα-p53-mediated transcriptional regulation, and could generate changes epigenetic in histone methylation [121]. Here, TP53 is linked to breast carcinoma.